1. Home
  2. Live Updates
  3. Maplight therapeutics

Live Breaking News & Updates on Maplight Therapeutics

Stay updated with breaking news from Maplight therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Psychiatry drugs finally have pharma's attention. Can they keep it?

BioPharma ....

United States , Sumitomo Pharma , Andrew Miller , Paul Matteis , Paul Kenny , Bristol Myers , Mitzi Gonzales , Bristol Myer Hargreaves , Alex Beckett , Daphne Zohar , Joseph Vu , Jose Luis Calvin Martin , Eli Lilly , Graig Suvannavejh , Jose Enrique Garcia Maurino Muzquiz , Jeffrey Lieberman , David Feinberg , Neurocrine Biosciences , Richard Hargreaves , Columbia University Medical Center , Drug Administration , Boehringer Ingelheim , Bristol Myers Squibb , Cantor Fitzgerald , Puretech Health , Jazz Pharmaceuticals ,

MAPLIGHT THERAPEUTICS APPOINTS MARIA WALKER TO BOARD OF DIRECTORS

/PRNewswire/ MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of. ....

San Diego , United States , Christopher Kroeger , Maria Walker , Montes Archimedes Acquisition Corp , Audit Committee , University Of California , Maplight Therapeutics , Chief Executive Officer , Founding Partner , Chief Financial Officer , Patient Square Capital , Area Asset Management , Senior Director , Venture Capital , Administrative Partner , Chief Operating Officer , Forward Ventures , Lightspeed Venture , Audit Committee Chairman , Montes Archimedes Acquisition ,

MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR ML-007/PAC, UNDER DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER'S DISEASE PSYCHOSIS

/PRNewswire/ MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of. ....

United States , Christopher Kroeger , John Kane , Maplight Therapeutics , Chief Executive Officer , Barbara Zucker School ,

MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR ML-007/PAC, UNDER DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER'S DISEASE PSYCHOSIS

MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR ML-007/PAC, UNDER DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER'S DISEASE PSYCHOSIS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , John Kane , Christopher Kroeger , Charmaine Lykins , Maplight Therapeutics Inc , Maplight Therapeutics , Chief Executive Officer , Barbara Zucker School , Chief Commercial Officer , Light Therapeutics ,

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)

/PRNewswire/ Novo Holdings today announced its financial results for 2023 . Strong Investment Portfolio performance, and growth of the Novo Group companies. ....

United States , Hong Kong , Limmatech Biologics , Kasim Kutay , Hillstar Bio , Novo Nordisk , Oxford Biomedica , Acesion Pharma , Terremoto Biosciences , Contract Development , Pureos Bioventures Fund , Impact Fund , Novo Holding , Novo Holdings , Novo Group , Scion Fundi Venture Investments , Novo Group Companies , Biogeneration Capital Fund , Novo Nordisk Foundation , Value Of The Holding , Novo Holdings Investment Portfolio , Manufacturing Organisation , Paratek Pharmaceuticals , Octave Health , Strong Investment Portfolio , Total Income ,